Skip to main content
Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
25.29
+2.79 (12.40%)
At close: Mar 6, 2026, 4:00 PM EST
25.25
-0.04 (-0.16%)
After-hours: Mar 6, 2026, 7:24 PM EST

Sutro Biopharma Revenue

Sutro Biopharma had revenue of $9.69M in the quarter ending September 30, 2025, with 13.77% growth. This brings the company's revenue in the last twelve months to $105.65M, down -34.36% year-over-year. In the year 2024, Sutro Biopharma had annual revenue of $62.04M, down -59.64%.

Revenue (ttm)
$105.65M
Revenue Growth
-34.36%
P/S Ratio
3.92
Revenue / Employee
$593,517
Employees
178
Market Cap
414.45M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202462.04M-91.69M-59.64%
Dec 31, 2023153.73M85.96M126.84%
Dec 31, 202267.77M5.89M9.52%
Dec 31, 202161.88M19.16M44.84%
Dec 31, 202042.72M-14.00K-0.03%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

STRO News

More News